Buy or sell Synthego stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Synthego Stock
Genome Engineering Solutions
About Synthego Stock
Synthego is a developer of a precision tool designed to automate genome engineering research.The company's tool incorporates the use of informatics and machine learning and brings precision and automation to genome engineering, enabling genetic engineers and medical professionals to conduct rapid and cost-effective research with consistent results for every scientist.
Investors
8VC
Guardant Health, AnchorFree, Sila Nanotechnologies, Illumio, Blend, Synthego, Asana, Addepar, Hims, Blink Health
Alexandria Venture
Arab Angel Fund
Founders Fund
Lyft, SpaceX, Spotify, Airbnb, Palantir Technologies, Stripe, Wish, Compass, Eat Just, Inc., Flexport
Intel Capital
DocuSign, Joby Aviation, MongoDB, Synthego, Sprinklr, Kabam, Mirantis, Venafi, Kaltura, Joyent
Menlo Ventures
Uber, Chime, Machine Zone, Tintri, Roku, Minted, Betterment, Rover, Synthego, Recursion Pharmaceuticals
ZhenFund
Funding History
| June 2013 | $8.3M |
|---|---|
| December 2016 | $41.9M |
| December 2016 | $4.4M |
| October 2018 | $116M |
| June 2020 | $100M |
Management
Chief Executive Officer
Paul Dabrowski
Press
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Synthego or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
